. . . . . . . . . . "2018-12-07T00:00:00Z"^^ . . . . . . . . . . "30573964" . . . "Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes"@nl . . "article scientifique publi\u00E9 en 2018"@fr . . . . . . . . . . . . . . "Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes"@nl . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0433\u0440\u0443\u0434\u043D\u0456 2018"@uk . . . . . . "scientific article published on 07 December 2018"@en . . "Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes"@en . . . . . . . . . . "Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes"@nl . . . . "419-428" . "Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes"@en . . "Jessica W Skelley" . . . . . . . . . . . . . . . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u n'avientu de 2018"@ast . "Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes"@en . . "14" . . . . . . . . . . . . "im Dezember 2018 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . "Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes"@en . . . . "10.2147/VHRM.S168472" . . . . . . "wetenschappelijk artikel"@nl . . "Brooke S Carter" . . . "6292223" . . . . . . . . . . . . . . . . . . . . . . . . . . .